Onco Wiki / Krankheit

Glioblastom (IDH-WT, WHO-Grad 4)

Deterministische Ansicht der Quelle YAML Entität. Klinische Autorität bleibt mit den zitierten Quell-IDs und Rezensenten Sign-off Zustand.

IDDIS-GBM
ArtErkrankung
Aliase
GBMGlioblastomGlioblastoma multiforme (Legacy-Begriff)Гліобластома (IDH-WT, WHO grade 4)
Statusreviewed 2026-04-26 | pending_clinical_signoff
ErkrankungenNone declared
QuellenSRC-EANO-GBM-2024 SRC-NCCN-CNS-2025

Informational support. All recommendations must be verified by a qualified oncologist. Engineering checks are not clinical validation or treatment approval.

Quelle: YAML

icd_o_3_morphology9440/3
icd_o_3_topography["C71"]
icd_10C71
who_classificationWHO-ZNS-Tumors 5. ed (2021): Glioblastom, IDH-Wildtyp, Grad 4 (das IDH -mutante Grad-4 Astrozytom ist eine eigenständige Einheit)

Fähigkeiten

Anmerkungen

Scaffolded for batch #2: 4 RFs (intracranial-pressure emergency, MGMT-actionability, frailty/age — elderly Stupp-modified, biopsy-only vs maximal-safe-resection MDT-trigger). 1 regimen (TMZ Stupp concurrent + adjuvant). 2 indications (Stupp full for fit; TMZ-only for elderly unmethylated unfit). 1 algorithm. Lineage value `carcinoma` is suboptimal — neuroepithelial would be more accurate. Schema's lineage field is free-text Optional; using `carcinoma` for now to match other solid-tumor entries; clinical authors may want to add `glioma` / `neuroepithelial` enum value in future. RT 60 Gy / 30 fractions concurrent with TMZ 75 mg/m²/d daily during RT is the canonical Stupp concurrent phase. RT NOT modellable per PROPOSAL §17 — treated as free-text in Indication.notes for now.

Verwendet von

Therapeutische Relevanz

Algorithmen

Erkrankung

Anwendungsgebiet

Fragebogen

Warnhinweis

Quellen